We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$148B
AUM Growth
+$8.19B
Cap. Flow
+$6.46B
Cap. Flow %
4.35%
Top 10 Hldgs %
18.71%
Holding
2,935
New
79
Increased
1,853
Reduced
707
Closed
50

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$495M
2
MSFT icon
Microsoft
MSFT
+$480M
3
GPN icon
Global Payments
GPN
+$400M
4
MA icon
Mastercard
MA
+$274M
5
CMCSA icon
Comcast
CMCSA
+$254M

Sector Composition

Rank Sector Weight
1 Technology 18.77%
2 Financials 14.07%
3 Healthcare 13.13%
4 Consumer Discretionary 12.1%
5 Communication Services 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCI icon
2426
HCI Group
HCI
$2.41B
$293K ﹤0.01%
+6,969
New +$287K
PDFS icon
2427
PDF Solutions
PDFS
$2.07B
$293K ﹤0.01%
22,400
CAI
2428
DELISTED
CAI International, Inc.
CAI
$291K ﹤0.01%
13,360
+2,850
+27% +$62.9K
REX icon
2429
REX American Resources
REX
$1.41B
$289K ﹤0.01%
22,752
+20,292
+825% +$251K
AKRX
2430
DELISTED
Akorn Inc
AKRX
$289K ﹤0.01%
76,001
+5,634
+8% +$20.1K
TW icon
2431
Tradeweb Markets
TW
$21.6B
$288K ﹤0.01%
7,796
+840
+12% +$37.1K
CENX icon
2432
Century Aluminum
CENX
$5.07B
$288K ﹤0.01%
43,348
-21,049
-33% -$139K
AGM icon
2433
Federal Agricultural Mortgage
AGM
$2.56B
$286K ﹤0.01%
3,500
NERV icon
2434
Minerva Neurosciences
NERV
$199M
$286K ﹤0.01%
4,608
+1,308
+40% +$74.1K
LDL
2435
DELISTED
Lydall, Inc.
LDL
$284K ﹤0.01%
+11,402
New +$243K
PDLI
2436
DELISTED
PDL BioPharma, Inc.
PDLI
$284K ﹤0.01%
131,334
+9,953
+8% +$26.6K
HY icon
2437
Hyster-Yale Materials Handling
HY
$665M
$284K ﹤0.01%
5,180
+1,180
+30% +$65.6K
NTR icon
2438
Nutrien
NTR
$30.7B
$283K ﹤0.01%
5,669
+4,903
+640% +$250K
CDR
2439
DELISTED
Cedar Realty Trust, Inc
CDR
$282K ﹤0.01%
14,233
+884
+7% +$14.9K
SPOK icon
2440
Spok Holdings
SPOK
$241M
$281K ﹤0.01%
23,528
+1,503
+7% +$19.4K
CBB
2441
DELISTED
Cincinnati Bell Inc.
CBB
$279K ﹤0.01%
54,993
+10,029
+22% +$49.1K
REVG
2442
DELISTED
REV Group
REVG
$277K ﹤0.01%
24,198
+13,898
+135% +$172K
AZN icon
2443
AstraZeneca
AZN
$250B
$276K ﹤0.01%
3,098
+624
+25% +$54.1K
TTGT icon
2444
TechTarget
TTGT
$278M
$275K ﹤0.01%
12,200
+291
+2% +$6.69K
BNFT
2445
DELISTED
Benefitfocus, Inc.
BNFT
$274K ﹤0.01%
11,501
CTMX icon
2446
CytomX Therapeutics
CTMX
$753M
$273K ﹤0.01%
37,054
+8,490
+30% +$83.8K
ASTE icon
2447
Astec Industries
ASTE
$1.02B
$270K ﹤0.01%
8,679
+8,653
+33,281% +$263K
PRTA icon
2448
Prothena Corp
PRTA
$459M
$269K ﹤0.01%
34,267
+3,452
+11% +$30.7K
AXSM icon
2449
Axsome Therapeutics
AXSM
$10.9B
$268K ﹤0.01%
13,244
-9,983
-43% -$257K
LPG icon
2450
Dorian LPG
LPG
$1.96B
$267K ﹤0.01%
25,800
+7,400
+40% +$72.4K

Similar funds

UBS AM's Q3 2019 Portfolio in Review

As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $167M trimmed.

  • UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
  • UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
  • UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
  • UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
  • UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
  • UBS AM opened 79 new positions and closed 50 in Q3 2019.
  • UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.

Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.